SOURCE-LINKED INTELLIGENCE

POPULATION-BASED EVALUATION OF ARTIFICIAL INTELLIGENCE FOR MAMMOGRAPHY PRIOR TO WIDESPREAD CLINICAL TRANSLATION - PROJECT SUMMARY MULTIPLE ARTIFICIAL INTELLIGENCE (AI) TECHNOLOGIES ARE NOW COMMERCIALLY AVAILABLE FOR AUTO

USAspending · observation · Publication date unknown

POPULATION-BASED EVALUATION OF ARTIFICIAL INTELLIGENCE FOR MAMMOGRAPHY PRIOR TO WIDESPREAD CLINICAL TRANSLATION - PROJECT SUMMARY MULTIPLE ARTIFICIAL INTELLIGENCE (AI) TECHNOLOGIES ARE NOW COMMERCIALLY AVAILABLE FOR AUTOMATED INTERPRETATION OF SCREENING MAMMOGRAPHY. THESE AI TECHNOLOGIES HOLD PROMISE FOR IMPROVING SCREENING PERFORMANCE AND OUTCOMES FOR THE 40 MILLION U.S. WOMEN WHO UNDERGO ROUTINE BREAST CANCER SCREENING EACH YEAR. FEDERAL REGULATORY APPROVAL OF NEW AI TECHNOLOGIES REQUIRES ONLY A DEMONSTRATION OF NON-INFERIOR ACCURACY TO EXISTING COMPUTER-AIDED DETECTION SYSTEMS IN SMALL, RET

Read original source ↗ Open in workspace

recordType

award

region

US

value

3238880

unit

USD